Business description
Demant is a world-leading hearing healthcare and technology group built on a heritage of care, health and innovation since 1904. The Group offers innovative technologies, solutions and know-how to help improve people’s health and hearing. In every aspect, from hearing care, hearing aids and hearing implants to diagnostic equipment and services and audio solutions, Demant is active and engaged. Headquartered in Denmark, the Group employs approx. 16,500 people globally and is present with solutions in 130 countries where we create life-changing hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen as a blue chip stock.
Management board & Supervisory board
| CEO |
| Søren Nielsen |
| Management board |
| René Schneider, Niels Wagner, Anne-Karen Hunt |
| Supervisory board |
| Niels B. Christiansen, Niels Jacobsen, Thomas Duer, Heidir Hørby, Sisse Fjelsted Rasmussen, Kristian Villumsen, Anders Højsgaard Thomsen |
Company data
| Name: |
Demant A/S |
| Address: |
Kongebakken 9,DK-2765 Smørum |
| Phone: |
+45-3917-7300 |
| Fax: |
+45-3927-7900 |
| E-mail: |
info@demant.com
|
| Internet: |
www.demant.com/ |
| Industry Group: |
Healthcare |
| Industry: |
Healthcare products |
| Sector: |
Healthcare/ Information Technology |
| Subsector: |
Healthcare - Information Technology |
| End of financial year: |
12-31 |
| Free Float: |
44.00% |
| IPO date: |
- |
Investor relations
| Name: |
Peter Pudselykke |
| IR phone: |
+45-3917-7300 |
| IR Fax: |
- |
| IR e-mail: |
pepu@demant.com
|
